Skip to Main Content

Paper Details

A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.
Breast Cancer Res
32
2019
-125b, -miRNA pair, BC, ER, ER- and HER2-negative tumors, HER2, MYC, PI3K, PTEN, PTEN mRNA, Pten, RB1, TNBC, TNBC-like lesions, TNBCs, TP53, TP53 mutation, Triple-negative breast cancer, Wnt, and -catenin, catenin, has, has-miR136, hsa, hsa-miR-145, hsa-miR-381, hsa-miR-4324, human, mRNA, miR, miRNA, miRNAs, miRs, mice, microRNA, microRNA-145, microRNAs, patients, triple-negative breast cancer
Author NameAffiliation
Dong-Yu WangToronto General Research Institute - University Health Network, 67 College Street
Deena M A GendooInstitute of Cancer and Genomic Sciences, University of Birmingham
Deena M A GendooInstitute of Cancer and Genomic Sciences, University of Birmingham
James R WoodgettLunenfeld-Tanenbaum Research Institute, University Avenue
Eldad ZacksenhausToronto General Research Institute - University Health Network, 67 College Street
Eldad ZacksenhausUniversity of Toronto
  • 1 - 6

Datasets

Release 1.2